Seres Therapeutics, Inc. (1S90)
Market Closed
17 Jul, 20:00
XFRA 
€
4. 38
-0.23
-4.8807%
€
61.49M Market Cap
- P/E Ratio
- Div Yield
50 Volume
-0.99 Eps
€ 4.61
Previous Close Want to track 1S90 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
1S90 Earnings Reports FAQ
What is the earnings per share (EPS) for 1S90?
The current EPS is -0.99.
What is the company's earnings growth rate?
Seres Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Seres Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Seres Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 1S90 at this time, as Seres Therapeutics, Inc has no recent EPS data to calculate it.
